FIGS (NYSE:FIGS) Stock Price Up 4.3%

Shares of FIGS, Inc. (NYSE:FIGS) rose 4.3% during mid-day trading on Tuesday . The stock traded as high as $6.51 and last traded at $6.49. Approximately 586,547 shares changed hands during trading, a decline of 84% from the average daily volume of 3,653,211 shares. The stock had previously closed at $6.22.

Analyst Ratings Changes

FIGS has been the subject of several research analyst reports. Bank of America restated an “underperform” rating and set a $4.50 price target (down previously from $8.50) on shares of FIGS in a research note on Tuesday, April 2nd. Telsey Advisory Group reiterated a “market perform” rating and issued a $6.00 price objective on shares of FIGS in a research note on Thursday, June 13th. Roth Mkm reduced their price objective on shares of FIGS from $7.50 to $6.75 and set a “buy” rating for the company in a research note on Friday, May 10th. Finally, The Goldman Sachs Group reduced their price objective on shares of FIGS from $4.85 to $4.25 and set a “sell” rating for the company in a research note on Tuesday, April 23rd. Two research analysts have rated the stock with a sell rating, three have issued a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $5.30.

FIGS Stock Performance

The business’s 50-day moving average price is $5.37 and its 200 day moving average price is $5.44. The stock has a market capitalization of $1.14 billion, a PE ratio of 59.73, a price-to-earnings-growth ratio of 79.20 and a beta of 1.42.

FIGS (NYSE:FIGS) last released its quarterly earnings results on Thursday, May 9th. The company reported $0.01 EPS for the quarter, beating analysts’ consensus estimates of ($0.01) by $0.02. The firm had revenue of $119.29 million during the quarter, compared to analyst estimates of $117.38 million. FIGS had a net margin of 4.07% and a return on equity of 6.12%. The business’s revenue for the quarter was down .8% on a year-over-year basis. During the same period in the previous year, the business earned $0.01 EPS. As a group, equities research analysts predict that FIGS, Inc. will post 0.03 earnings per share for the current year.

Insider Activity

In other news, insider Heather L. Hasson sold 28,614 shares of the business’s stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $4.89, for a total transaction of $139,922.46. Following the completion of the transaction, the insider now directly owns 468,870 shares in the company, valued at approximately $2,292,774.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders sold 32,649 shares of company stock worth $161,206 in the last three months. Corporate insiders own 22.30% of the company’s stock.

Institutional Trading of FIGS

Hedge funds have recently made changes to their positions in the stock. Wellington Management Group LLP bought a new stake in shares of FIGS during the 3rd quarter worth $4,306,000. Eagle Asset Management Inc. bought a new stake in shares of FIGS during the 4th quarter worth $12,152,000. ProShare Advisors LLC lifted its holdings in shares of FIGS by 26.6% during the 1st quarter. ProShare Advisors LLC now owns 766,465 shares of the company’s stock worth $3,817,000 after acquiring an additional 161,249 shares during the last quarter. Applied Fundamental Research LLC lifted its holdings in shares of FIGS by 25.8% during the 1st quarter. Applied Fundamental Research LLC now owns 2,495,381 shares of the company’s stock worth $12,427,000 after acquiring an additional 511,794 shares during the last quarter. Finally, SG Americas Securities LLC lifted its stake in FIGS by 64.3% in the fourth quarter. SG Americas Securities LLC now owns 49,467 shares of the company’s stock worth $344,000 after purchasing an additional 19,353 shares during the last quarter. 92.21% of the stock is owned by institutional investors.

FIGS Company Profile

FIGS, Inc operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. It designs and sells healthcare apparel and scrubwear and non-scrubwear offerings, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel.